Deaths (Credit: Canva)
Heart disease and cancer maintained their grim distinction as the leading causes of death in the United States in 2023, together accounting for 40% of all fatalities. As per the latest data revealed by the CDC, the overall death rate from these conditions saw modest declines. However. COVID-19 dropped significantly to become the 10th leading cause of death, indicating that its impact had reduced.
Cardiovascular disease remained the leading cause of death among the people. According to the latest report by the National Center for Health Statistics, deaths from heart disease were recorded at 162.1 in 2023. This was a slight decline from 167.2 per 100,000 people in 2022. Cancer-related fatalities also declined marginally from 142.3 to 141.8 per 100,000. Despite these reductions, the two conditions remain at the top of the list.
Coronavirus, which held the fourth spot in 2022 with 44.5 deaths per 100,000 people, dropped significantly to 11.9 in 2023. This sharp decline reflects increased immunity, widespread vaccination efforts, and advancements in treatment protocols. However, the virus still claimed enough lives to remain among the top 10 causes of death.
Accidental deaths, the third leading cause, showed a slight reduction, decreasing from 64.0 per 100,000 in 2022 to 62.3 in 2023. Stroke-related deaths also dipped marginally, from 39.5 to 39 per 100,000, while chronic lower respiratory diseases declined from 34.3 to 33.4. These changes, though minor, suggest ongoing efforts to address risk factors in the healthcare system.
Other conditions that showed decline were Alzheimer's disease, diabetes, kidney disease, and chronic liver disease. Deaths from Alzheimer's, which is a neurodegenerative disease, fell from 28.9 per 100,000 in 2022 to 27.7 in 2023. Diabetes-related fatalities decreased from 24.1 to 22.4 per 100,000. Meanwhile, kidney disease and chronic liver disease dropped to 13.1 and 13.0 per 100,000, respectively, from 13.8 each in the prior year.
ALSO READ: Why Is Snow Shoveling Risky For Your Heart?
This report comes as the US and other Western countries are witnessing extremely cold weather. Recent research has found that shovelling snow, which may seem like a routine winter task, poses significant health risks, particularly for the heart. The cold temperatures combined with physical exertion can strain the cardiovascular system, increasing the likelihood of heart attacks. A study by the American Heart Association (AHA) linked heavy snowfall (7–8 inches) to a 16% increase in heart attack hospitalizations among men and a 34% rise in fatal heart attacks. Moreover, these constricted blood vessels also contribute to high blood pressure, exacerbating the risks of brain stroke.
ALSO READ: France Bans Sale of Eight Cold Medicines Due to Health Risks
Credits: Canva
Every year on September 17, the world pauses to reflect on one of the most pressing challenges in healthcare, patient safety. Since its launch by the World Health Organization (WHO) in 2019, World Patient Safety Day has become a global campaign calling for stronger collaboration, awareness, and action to prevent avoidable harm in healthcare systems.
In 2025, the theme is “Safe care for every newborn and every child”, with the slogan “Patient safety from the start!”. The message is clear: children are not just fragile as they do not have the same levels of immunity as adults, they require special attention, protection, and tailored medical care from the very beginning of life.
Patient safety is not an isolated goal; it is the very foundation of healthcare. Without safe practices, no system can achieve universal health coverage or progress toward the Sustainable Development Goals (SDGs). The WHO emphasizes that unsafe care remains one of the top ten causes of death and disability worldwide, disproportionately affecting vulnerable groups such as newborns and children.
Children are particularly vulnerable to risks in healthcare. Unlike adults, they cannot decide which clinic to visit or which treatment to accept. They must rely entirely on parents, caregivers, and healthcare professionals. Their smaller bodies, developing immune systems, and emotional needs mean they often respond differently to illness and medical interventions.
The German Coalition for Patient Safety (APS) stresses that children should not be treated through an “adult lens.” Its slogan for 2025: “Patient safety from childhood onwards, an investment for life", captures the long-term importance of safe care for the youngest patients. APS is also encouraging parents, pediatricians, obstetricians, and nurses to share their experiences and identify both strengths and gaps in healthcare delivery.
The urgency of this year’s theme is evident in global statistics. WHO’s Regional Director for Africa, Dr. Mohamed Janabi, recently highlighted that poor quality care, rather than lack of access, accounts for 60% of maternal deaths and 56% of neonatal deaths in low- and middle-income countries.
While access to hospitals has improved in many regions, unsafe practices, such as inadequate infection prevention, misdiagnosis, or insufficiently trained staff, continue to harm patients. Encouragingly, 21 African countries have already introduced National Quality Policies and Strategies that include patient safety measures like infection control, but more progress is needed.
World Patient Safety Day campaigns in previous years have focused on areas such as safe childbirth, medication safety, health worker safety, and diagnostic safety. This year’s emphasis on paediatric and newborn care builds on those efforts, recognizing that safety at the start of life shapes long-term health outcomes.
World Patient Safety Day 2025 is not just about raising awareness, it is also about mobilizing concrete action. Governments, hospitals, professional associations, and civil society organizations are being urged to implement sustainable strategies to safeguard children’s health. Parents and caregivers, too, are encouraged to actively participate in their child’s medical journey by asking questions, understanding treatment plans, and advocating for safe care.
Around the world, awareness activities will include advocacy campaigns, technical discussions, and the illumination of landmarks in orange, the signature color of the campaign. These symbolic gestures serve as powerful reminders that safe healthcare is a universal right, not a privilege.
This year’s slogan, “Patient safety from the start!”, underscores that ensuring safe care from birth is not optional, it is essential. Protecting children from avoidable harm is both a moral responsibility and an investment in healthier societies.
World Patient Safety Day 2025 is a reminder that safe care is achievable when everyone, from policymakers to frontline nurses, and from parents to international organizations, works together. After all, safeguarding the health of children today ensures a stronger, healthier world tomorrow.
Credits: Canva
Just 10 days after the Democratic Republic of the Congo (DRC) declared an Ebola virus outbreak in Kasai province, health authorities have rolled out a vaccination drive targeting frontline workers and contacts of patients, the World Health Organization (WHO) confirmed in its latest update.
The first consignment of 400 doses of Ervebo (VSV-EBOV) was dispatched to Bulape health zone from a national stockpile of 2,000 doses stored in Kinshasa. Some frontline health workers in the capital had already received the vaccine. The WHO said additional shipments are expected in the coming days to sustain the response effort.
Health teams are deploying a “ring vaccination” strategy, which prioritizes those at the highest risk of infection, including patient contacts and health workers directly exposed to cases.
To ensure adequate coverage, the International Coordinating Group on Vaccine Provision has approved an additional 45,000 doses to be sent to the DRC. The WHO is assisting the Ministry of Health in formalizing a request for these doses and has also worked with partners to draw up a detailed immunization plan. Training sessions for vaccination teams are underway to streamline the rollout.
Alongside vaccines, treatment options are being reinforced. Courses of the monoclonal antibody therapy MAb114 (ansuvimab-zykl, commercially known as Ebanga) have already been dispatched to treatment centers in Bulape to support patient care.
Despite these interventions, the outbreak continues to grow. At a meeting of the provincial Ebola emergency committee on September 13, officials reported a sharp increase in infections and fatalities. According to the DRC’s National Public Health Laboratory (INRB), total cases have now risen to 81, with 28 deaths recorded, marking a case-fatality rate of 34.6%.
The latest figures represent a significant jump from a few days earlier, when authorities reported 68 suspected cases (including 20 confirmed) and 16 deaths.
Also Read: Congo Ebola Outbreak Caused By The Zaire Strain So Far Has 28 Deaths, Confirms WHO
Of seven new suspected cases detected in the Bulape health zone, five have been confirmed through laboratory testing. This highlights both the rapid spread of the virus and the crucial role of diagnostic capacity in containing the outbreak.
Efforts to trace and monitor contacts are also being scaled up. Health officials identified 58 new contacts in recent days, bringing the total to 716. Contact tracing is a cornerstone of the response, enabling teams to vaccinate and monitor individuals most likely to have been exposed.
In a further boost to local capacity, another 360 vaccine doses have arrived in Tshikapa, the provincial capital of Kasai. This shipment is expected to support wider vaccination efforts in neighboring areas.
With Ebola continuing to claim lives in Kasai, health authorities in the DRC and their global partners are racing to contain the outbreak. Vaccines, therapeutic drugs, and intensive contact tracing remain at the heart of the strategy. However, the rising case count underscores the urgent need to maintain momentum and secure sufficient supplies before the virus spreads further.
Credits: Canva
Amoebic meningoencephalitis, a rare and often deadly brain infection caused by the free-living amoeba Naegleria fowleri, has recently raised alarms in Kerala. The state confirmed a new case involving a 17-year-old boy from Thiruvananthapuram, intensifying concerns amid the ongoing 2025 outbreak. Known as the “brain-eating amoeba,” this infection enters the body through the nose and attacks the brain, causing rapid health deterioration and a high risk of death.
The boy is believed to have contracted the infection while bathing in a pool with friends. Following the diagnosis, the Kerala health department has closed the swimming pool at Akkulam Tourist Village and sent water samples for testing.
Brain-Eating Amoeba: What Is This Brain Infection?Brain-eating amoeba is a type of amoeba that usually lives in warm freshwater or unclean, untreated water. When it enters the human body, it causes a deadly infection that inflames and destroys brain tissue. Medically, this condition is called primary amoebic meningoencephalitis (PAM).
You can only contract this infection if water contaminated with the amoeba enters your nose. While Naegleria exists in several species, only Naegleria fowleri is responsible for causing PAM.
ALSO READ: Panic In Kerala As Brain-Eating Amoeba Claims 5 Lives In A Month, 11 Under Watch
ALSO READ: ICMR Flags Misuse Of Critical Drugs, Suggests New Antibiotics Be Sold Only In Hospitals
“We urge people to avoid swimming in unchlorinated or stagnant water and to maintain strict hygiene when using water bodies for bathing,” she said. The government has also acted swiftly by closing the implicated swimming pool and enhancing water safety testing protocols.
Prevention remains the most effective protection. Experts recommend:
To tackle waterborne diseases, Kerala has launched the comprehensive ‘Water is Life’ campaign under the Haritha Keralam Mission. This statewide effort emphasises chlorinating wells, cleaning public water sources, and running awareness programmes in schools and local communities.
© 2024 Bennett, Coleman & Company Limited